As you can see, this stock has been maintaining a steady and consistent uptrend, showing strong price structure over time.
On the fundamental side, the story remains equally compelling, with a healthy upward revision to full-year guidance and notable confidence from major institutions that have been aggressively raising their price targets.
Management also increased full-year EPS guidance to a range of $7.50 to $7.74, up from the previous $7.02 to $7.36, which comes in comfortably above Wall Street’s pre-earnings consensus of around $7.31 to $7.32. Overall, both the technical trend and improving fundamentals appear aligned, supporting the ongoing bullish momentum.
On the fundamental side, the story remains equally compelling, with a healthy upward revision to full-year guidance and notable confidence from major institutions that have been aggressively raising their price targets.
Management also increased full-year EPS guidance to a range of $7.50 to $7.74, up from the previous $7.02 to $7.36, which comes in comfortably above Wall Street’s pre-earnings consensus of around $7.31 to $7.32. Overall, both the technical trend and improving fundamentals appear aligned, supporting the ongoing bullish momentum.
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.